✦ LIBER ✦

3 P Prophylaxis of HBV recurrence after liver transplantation in HBsAg-carriers. HBIG and lamivudine theraphy vs HBIG monotheraphy

✍ Scribed by A. Marzano; V. Ciardo; E. Gentilcore; S. Gaia; V. Ghisetti; M. Lagget; A. Smedile; M. Rizzetto

Book ID: 119631176
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 194 KB
Volume: 34
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(02)90221-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

One month of lamivuidine plus HBIg follo

One month of lamivuidine plus HBIg followed by lamivudine vs lamivudine + HBIg in the prevention of HBV recurrence after liver transplant

✍ M. Buti; A. Mas; M. Prieto; F. Casafont; A. González; M. Miras; J.I. Herrero; E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Human B immunoglobuline (HBIG) monothera

Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

✍ S. Gaia; A. Marzano; V. Ciardo; E. Gentilcore; M. Lagget; A. Smedile; M. Rizzett 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Prolonged follow-up of HBV liver transpl

Prolonged follow-up of HBV liver transplanted patients: results from a randomized study comparing lamivudine vs. lamivudine+HBIG in the prevention of HBV recurrence after liver transplantation

✍ M. Buti; A. Mas; M. Prieto; F. Casafont; A. Gonzalez; M. Miras; A. Valdes; J. He 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Failure of hepatitis B vaccination with

Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation

✍ Jens Rosenau; Nazanin Hooman; Johannes Hadem; Kinan Rifai; Matthias J. Bahr; Gun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Hepatitis B vaccination after liver transplantation for hepatitis B-related liver disease has been investigated as an alternative strategy to reinfection prophylaxis with hepatitis B immunoglobulin (HBIG) with conflicting results. In most studies, HBIG treatment was discontinued before vaccination.